Thermo Fisher Scientific invites clients at all points on their pathway to commercialization, whether they’re an emerging biotech developing a rare disease therapy or a high-volume pharmaceutical manufacturer to learn how we are increasing capabilities and capacity to meet growing demand. Join us for a live webcast that will announce the 2020 investments to our Pharma Services business and offer insights into the latest news related to:
- Biologics development and manufacturing
- Cell and gene therapy capabilities
- Expanded Drug product development and commercial capabilities
We will also cover our strategy to ensure the delivery of drugs to customers and patients in lieu of the COVID-19 outbreak.
For each person that attends the webcast, Thermo Fisher will donate a toy from the wish list at NewYork-Presbyterian Morgan Stanley Children’s Hospital on your behalf as our way of showing our appreciation for your continued commitment to serving patients.
Speakers:
Mike Shafer
SVP & President, Pharma Services,
Thermo Fisher Scientific
Mike Shafer joined Pharma Services in October of 2019. He is well positioned to lead the business after a strong track record of leading high-growth businesses within Thermo Fisher including Thermo Fisher China and the Chemical Analysis Division, following FEI’s acquisition. Mike has an intense commitment to customers, operational focus and ability to build strong teams.
Leon Wyszkowski
President, Commercial Operations,
Thermo Fisher Scientific
Leon Wyszkowski joined Thermo Fisher Scientific in 2006 and since then he has held positions of increased responsibility including his previous position as President, Clinical Trials Division. He has worked in drug development for more than 22 years, with extensive experience in operations, client services and supply chain logistics.
